1. Home
  2. TENX vs CLPT Comparison

TENX vs CLPT Comparison

Compare TENX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.50

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$19.43

Market Cap

353.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
CLPT
Founded
1967
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
353.5M
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
TENX
CLPT
Price
$13.50
$19.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$29.67
$20.00
AVG Volume (30 Days)
1.2M
872.9K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$36,971,000.00
Revenue This Year
N/A
$45.67
Revenue Next Year
N/A
$19.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.78
52 Week Low
$5.67
$8.27
52 Week High
$18.38
$30.10

Technical Indicators

Market Signals
Indicator
TENX
CLPT
Relative Strength Index (RSI) 64.01 75.01
Support Level $13.16 $12.55
Resistance Level $14.15 $27.64
Average True Range (ATR) 0.81 1.33
MACD 0.31 0.41
Stochastic Oscillator 91.71 96.40

Price Performance

Historical Comparison
TENX
CLPT

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Share on Social Networks: